OBJECTIVE: To develop a Radiation Therapy Oncology Group (RTOG) atlas delineating gross tumor volume (GTV) and clinical target volume (CTV) to be used for preoperative radiotherapy of primary extremity soft tissue sarcoma (STS). METHODS AND MATERIALS: A consensus meeting was held during the RTOG meeting in January 2010 to reach agreement about GTV and CTV delineation on computed tomography (CT) images for preoperative radiotherapy of high-grade large extremity STS. Data were presented to address the local extension of STS. Extensive discussion ensued to develop optimal criteria for GTV and CTV delineation on CT images. RESULTS: A consensus was reached on appropriate CT-based GTV and CTV. The GTV is gross tumor defined by T1 contrast-enhanced magnetic resonance images. Fusion of magnetic resonance and images is recommended to delineate the GTV. The CTV for high-grade large STS typically includes the GTV plus 3-cm margins in the longitudinal directions. If this causes the field to extend beyond the compartment, the field can be shortened to include the end of a compartment. The radial margin from the lesion should be 1.5 cm, including any portion of the tumor not confined by an intact fascial barrier, bone, or skin surface. CONCLUSION: The consensus on GTV and CTV for preoperative radiotherapy of high-grade large extremity STS is available as web-based images and in a descriptive format through the RTOG. This is expected to improve target volume consistency and allow for rigorous evaluation of the benefits and risks of such treatment.
OBJECTIVE: To develop a Radiation Therapy Oncology Group (RTOG) atlas delineating gross tumor volume (GTV) and clinical target volume (CTV) to be used for preoperative radiotherapy of primary extremity soft tissue sarcoma (STS). METHODS AND MATERIALS: A consensus meeting was held during the RTOG meeting in January 2010 to reach agreement about GTV and CTV delineation on computed tomography (CT) images for preoperative radiotherapy of high-grade large extremity STS. Data were presented to address the local extension of STS. Extensive discussion ensued to develop optimal criteria for GTV and CTV delineation on CT images. RESULTS: A consensus was reached on appropriate CT-based GTV and CTV. The GTV is gross tumor defined by T1 contrast-enhanced magnetic resonance images. Fusion of magnetic resonance and images is recommended to delineate the GTV. The CTV for high-grade large STS typically includes the GTV plus 3-cm margins in the longitudinal directions. If this causes the field to extend beyond the compartment, the field can be shortened to include the end of a compartment. The radial margin from the lesion should be 1.5 cm, including any portion of the tumor not confined by an intact fascial barrier, bone, or skin surface. CONCLUSION: The consensus on GTV and CTV for preoperative radiotherapy of high-grade large extremity STS is available as web-based images and in a descriptive format through the RTOG. This is expected to improve target volume consistency and allow for rigorous evaluation of the benefits and risks of such treatment.
Authors: T R Mackie; J Balog; K Ruchala; D Shepard; S Aldridge; E Fitchard; P Reckwerdt; G Olivera; T McNutt; M Mehta Journal: Semin Radiat Oncol Date: 1999-01 Impact factor: 5.934
Authors: Thomas Rockwell Mackie; Jeff Kapatoes; Ken Ruchala; Weiguo Lu; Chuan Wu; Gustavo Olivera; Lisa Forrest; Wolfgang Tome; Jim Welsh; Robert Jeraj; Paul Harari; Paul Reckwerdt; Bhudatt Paliwal; Mark Ritter; Harry Keller; Jack Fowler; Minesh Mehta Journal: Int J Radiat Oncol Biol Phys Date: 2003-05-01 Impact factor: 7.038
Authors: A M Davis; B O'Sullivan; R S Bell; R Turcotte; C N Catton; J S Wunder; P Chabot; A Hammond; V Benk; M Isler; C Freeman; K Goddard; A Bezjak; R A Kandel; A Sadura; A Day; K James; D Tu; J Pater; B Zee Journal: J Clin Oncol Date: 2002-11-15 Impact factor: 44.544
Authors: Brian O'Sullivan; Aileen M Davis; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph Pater; Benny Zee Journal: Lancet Date: 2002-06-29 Impact factor: 79.321
Authors: Dian Wang; Qiang Zhang; Burton L Eisenberg; John M Kane; X Allen Li; David Lucas; Ivy A Petersen; Thomas F DeLaney; Carolyn R Freeman; Steven E Finkelstein; Ying J Hitchcock; Manpreet Bedi; Anurag K Singh; George Dundas; David G Kirsch Journal: J Clin Oncol Date: 2015-02-09 Impact factor: 44.544
Authors: Jayashree Kalpathy-Cramer; Musaddiq Awan; Steven Bedrick; Coen R N Rasch; David I Rosenthal; Clifton D Fuller Journal: J Digit Imaging Date: 2014-02 Impact factor: 4.056
Authors: Nadya Shusharina; Xiaofeng Liu; Jaume Coll-Font; Anna Foster; Georges El Fakhri; Jonghye Woo; Thomas Bortfeld; Christopher Nguyen Journal: Phys Med Biol Date: 2022-07-22 Impact factor: 4.174
Authors: Brady S Laughlin; Michael A Golafshar; Safia Ahmed; Matthew Prince; Justin D Anderson; Tamara Vern-Gross; Mahesh Seetharam; Krista Goulding; Ivy Petersen; Todd DeWees; Jonathan B Ashman Journal: Int J Part Ther Date: 2022-05-06
Authors: Houda Bahig; David Roberge; Walter Bosch; William Levin; Ivy Petersen; Michael Haddock; Carolyn Freeman; Thomas F Delaney; Ross A Abrams; Danny J Indelicato; Elizabeth H Baldini; Ying Hitchcock; David G Kirsch; Kevin R Kozak; Aaron Wolfson; Dian Wang Journal: Int J Radiat Oncol Biol Phys Date: 2013-03-06 Impact factor: 7.038
Authors: R Correa; J Gómez-Millán; M Lobato; A Fernández; R Ordoñez; C Castro; Y Lupiañez; J A Medina Journal: Clin Transl Oncol Date: 2018-02-23 Impact factor: 3.405
Authors: Ramiz Abu-Hijlih; Sara Mheid; Fawzi Abuhijla; Wafa Asha; Issa Mohamad; Abdullah Alrashdan; Samer Alheet; Haitham Kana'an; Mohammad Abd Al-Raheem; Abdelatif Almousa Journal: Rep Pract Oncol Radiother Date: 2019-03-18
Authors: Fien Hoefkens; Charlotte Dehandschutter; Johan Somville; Paul Meijnders; Dirk Van Gestel Journal: Radiat Oncol Date: 2016-10-12 Impact factor: 3.481